Concepedia

Rim Shayakhmetov

RS

Statistics

Publications

5

Citations

340

H-Index

5

Active since

2020

Affiliations

Insilico Medicine (United States)(Current)

Insilicos (United States)

Hong Kong Science and Technology Parks Corporation

Rim Shayakhmetov is an author at Insilico Medicine (United States) specializing in drug discovery, pharmacy, and drug design.

ORCID

Publications per year

2020–2020

5

Publications

5

Potential 2019-nCoV 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

Alex Zhavoronkov, Vladimir Aladinskiy, Alexander Zhebrak et al. · ChemRxiv · 2020 · 105 citations · Full text

, , +14

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

Alex Zhavoronkov, Vladimir Aladinskiy, Alexander Zhebrak et al. · ChemRxiv · 2020 · 98 citations · Full text

, , +14

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

Alex Zhavoronkov, Vladimir Aladinskiy, Alexander Zhebrak et al. · ChemRxiv · 2020 · 64 citations · Full text

, , +14

Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality

Alex Zhavoronkov, Bogdan Zagribelnyy, Alexander Zhebrak et al. · ChemRxiv · 2020 · 44 citations · Full text

, , +15

Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality

Alex Zhavoronkov, Bogdan Zagribelnyy, Alexander Zhebrak et al. · ChemRxiv · 2020 · 29 citations · Full text

, , +15

1–5 of 5